These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 20861773

  • 21. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
    Kim HJ, Kim BS, Kim MJ, Kim SH, de Campos RO, Hernandes M, Semelka RC.
    J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
    Peterson MS, Baron RL, Murakami T.
    Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
    [Abstract] [Full Text] [Related]

  • 24. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
    Gatto A, De Gaetano AM, Giuga M, Ciresa M, Siciliani L, Miele L, Riccardi L, Pizzolante F, Rapaccini GL, Gasbarrini A, Giuliante F, Vecchio FM, Pompili M, Bonomo L.
    Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
    [Abstract] [Full Text] [Related]

  • 25. Gadobenate dimeglumine-enhanced liver MR imaging in cirrhotic patients: quantitative and qualitative comparison of 1-hour and 3-hour delayed images.
    Jeong WK, Byun JH, Lee SS, Won HJ, Kim KW, Shin YM, Kim PN, Lee MG.
    J Magn Reson Imaging; 2011 Apr; 33(4):889-97. PubMed ID: 21448954
    [Abstract] [Full Text] [Related]

  • 26. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI.
    Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW.
    Magn Reson Imaging; 2011 Nov; 29(9):1235-43. PubMed ID: 21907517
    [Abstract] [Full Text] [Related]

  • 27. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Rimola J, Forner A, Reig M, Vilana R, de Lope CR, Ayuso C, Bruix J.
    Hepatology; 2009 Sep; 50(3):791-8. PubMed ID: 19610049
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
    Gupta RT, Iseman CM, Leyendecker JR, Shyknevsky I, Merkle EM, Taouli B.
    AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Potential conditions causing impairment of selective hepatobiliary enhancement of gadobenate dimeglumine-enhanced delayed magnetic resonance imaging.
    Kim H, Kim MJ, Park MS, Cha SW, Lim JS, Yoo HS, Kim KW.
    J Comput Assist Tomogr; 2010 Jan; 34(1):113-20. PubMed ID: 20118733
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
    Pirovano G, Vanzulli A, Marti-Bonmati L, Grazioli L, Manfredi R, Greco A, Holzknecht N, Daldrup-Link HE, Rummeny E, Hamm B, Arneson V, Imperatori L, Kirchin MA, Spinazzi A.
    AJR Am J Roentgenol; 2000 Oct; 175(4):1111-20. PubMed ID: 11000175
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preoperative MRI of potential living-donor-related liver transplantation using a single dose of gadobenate dimeglumine.
    Lim JS, Kim MJ, Kim JH, Kim SI, Choi JS, Park MS, Oh YT, Yoo HS, Lee JT, Kim KW.
    AJR Am J Roentgenol; 2005 Aug; 185(2):424-31. PubMed ID: 16037515
    [Abstract] [Full Text] [Related]

  • 37. New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases.
    Piana G, Trinquart L, Meskine N, Barrau V, Beers BV, Vilgrain V.
    J Hepatol; 2011 Jul; 55(1):126-32. PubMed ID: 21145857
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation.
    Baird AJ, Amos GJ, Saad NF, Benson MD.
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):314-20. PubMed ID: 23721140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.